A detailed history of Sei Investments CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sei Investments CO holds 1,465,719 shares of EW stock, worth $135 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,465,719
Previous 558,031 162.66%
Holding current value
$135 Million
Previous $42.5 Million 229.18%
% of portfolio
0.21%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$72.54 - $95.56 $65.8 Million - $86.7 Million
907,688 Added 162.66%
1,465,719 $140 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $3.37 Million - $4.25 Million
54,595 Added 10.84%
558,031 $42.5 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $581,397 - $783,644
-8,392 Reduced 1.64%
503,436 $34.9 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $274,595 - $318,175
-3,373 Reduced 0.65%
511,828 $48.3 Million
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $4.36 Million - $4.96 Million
58,717 Added 12.86%
515,201 $42.6 Million
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $4.33 Million - $5.54 Million
-63,332 Reduced 12.18%
456,484 $34.1 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $4.35 Million - $5.67 Million
-52,822 Reduced 9.22%
519,816 $43 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $6.73 Million - $9.98 Million
77,841 Added 15.73%
572,638 $54.5 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $1.92 Million - $2.42 Million
18,843 Added 3.96%
494,797 $58.2 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $22.1 Million - $27.2 Million
-207,822 Reduced 30.39%
475,954 $61.7 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $8.95 Million - $10.7 Million
86,983 Added 14.58%
683,776 $77.4 Million
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $4.08 Million - $5.09 Million
48,612 Added 8.87%
596,793 $61.8 Million
Q1 2021

May 12, 2021

BUY
$78.68 - $90.67 $13.7 Million - $15.8 Million
173,911 Added 46.47%
548,181 $45.9 Million
Q4 2020

Feb 08, 2021

BUY
$71.69 - $91.23 $133,486 - $169,870
1,862 Added 0.5%
374,270 $34.1 Million
Q3 2020

Dec 04, 2020

SELL
$67.19 - $87.44 $279,644 - $363,925
-4,162 Reduced 1.11%
372,408 $29.7 Million
Q3 2020

Nov 06, 2020

BUY
$67.19 - $87.44 $2.48 Million - $3.23 Million
36,908 Added 10.87%
376,570 $30.1 Million
Q2 2020

Aug 17, 2020

BUY
$57.54 - $76.95 $11.6 Million - $15.5 Million
201,776 Added 146.34%
339,662 $23.5 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $1.79 Million - $2.39 Million
31,029 Added 29.04%
137,886 $31.1 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $1.36 Million - $2.11 Million
-25,995 Reduced 19.57%
106,857 $20.1 Million
Q4 2019

Feb 06, 2020

BUY
$71.7 - $82.09 $477,665 - $546,883
6,662 Added 5.28%
132,852 $31 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $887,243 - $1.09 Million
14,415 Added 12.9%
126,190 $27.8 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $585,047 - $676,047
-10,496 Reduced 8.58%
111,775 $20.6 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $3.47 Million - $4.64 Million
-72,459 Reduced 37.21%
122,271 $23.4 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $153,431 - $188,243
3,306 Added 1.73%
194,730 $33.6 Million
Q3 2018

Nov 08, 2018

SELL
$45.7 - $58.03 $2.44 Million - $3.1 Million
-53,445 Reduced 21.83%
191,424 $33.3 Million
Q2 2018

Aug 03, 2018

BUY
$42.45 - $51.3 $8.38 Million - $10.1 Million
197,413 Added 415.99%
244,869 $35.6 Million
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $6.3 Million - $8.04 Million
-169,401 Reduced 78.12%
47,456 $6.62 Million
Q4 2017

Feb 08, 2018

BUY
$33.79 - $39.39 $1.96 Million - $2.29 Million
58,050 Added 36.55%
216,857 $24.4 Million
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $5.76 Million - $6.17 Million
158,807
158,807 $17.4 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.